Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study

BACKGROUND: Rabeprazole at 10 or 20 mg twice daily (b.i.d.) has been reported to be highly effective in the treatment of proton pump inhibitor (PPI)-resistant reflux esophagitis (RE) that is refractory to the standard once-daily PPI regimen. We evaluated the efficacy and safety of rabeprazole mainte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastroenterol
Autors principals: Kinoshita, Yoshikazu, Kato, Mototsugu, Fujishiro, Mitsuhiro, Masuyama, Hironori, Nakata, Ryo, Abe, Hisanori, Kumagai, Shinji, Fukushima, Yasushi, Okubo, Yoshiumi, Hojo, Seiichiro, Kusano, Motoyasu
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2017
Matèries:
Original Article—Alimentary Tract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006226/
https://ncbi.nlm.nih.gov/pubmed/29188387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-017-1417-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars